Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 4Active not recruiting 4Not yet recruiting 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Genitourinary 1Breast 1

Conditions

Breast Neoplasms 155Neoplasms 113Carcinoma, Non-Small-Cell Lung 86Prostatic Neoplasms 84Colorectal Neoplasms 84Lung Neoplasms 72Carcinoma, Hepatocellular 51Leukemia, Myeloid, Acute 49Pancreatic Neoplasms 46Neoplasm Metastasis 41Multiple Myeloma 37Recurrence 35Triple Negative Breast Neoplasms 28Melanoma 28Squamous Cell Carcinoma of Head and Neck 27Precursor Cell Lymphoblastic Leukemia-Lymphoma 27Ovarian Neoplasms 27Head and Neck Neoplasms 27Glioblastoma 27Brain Neoplasms 26Uterine Cervical Neoplasms 25Stomach Neoplasms 24Small Cell Lung Carcinoma 24Rectal Neoplasms 24Endometrial Neoplasms 21Carcinoma, Renal Cell 21Lymphoma, Follicular 20Lymphoma, B-Cell 19Lymphoma 19Motor Activity 17

Interventions

fludarabine 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Sarcoma, Alveolar Soft Part × 90 days × Clear all
NCT07297667 2026-05-12

GCAR1, a Chimeric Antigen Receptor (CAR) T-CELL Therapy for Relapsed/Refractory GPNMB-Expressing Solid Tumours

Canadian Cancer Trials Group

Phase 1 Not yet recruiting
30 enrolled
BreastGenitourinarySarcoma

Carcinoma, Renal Cell, Sarcoma, Alveolar Soft Part, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡